Comirnaty

Medicinal product

(Invented) name

Comirnaty

Active substance (s)

COVID-19 mRNR vakcina. Tozinameranas

Strength

3 µg/dozėje

Pharmaceutical form

koncentratas injekcinei dispersijai

Route (s) of administration

leisti į raumenis

Purpose for use

6 mėn. kūdikiams - 4 m. vaikams

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J07BN01, covid-19, RNA-based vaccine

Marketing authorisation holder

BioNTech Manufacturing GmbH, Vokietija

Date of authorisation

2020-12-21

Date of renewal

Documents

Search in EMA Europe

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Concentrate for dispersion for injection. One dose (0.2 mL) contains:	0.2 ml
COVID-19 mRNR vakcina. Tozinameranas	3 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
109666	95772	1095772	flakonas	0,4 ml N10 (daugiadozis, 100 dozių)		Receptinis	EU/1/20/1528/010	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
	Išregistruotas
2020-12-21	Registruotas